Cargando…
Antiatherosclerotic effect of dehydrocorydaline on ApoE(−/−) mice: inhibition of macrophage inflammation
Despite improvements in cardiovascular disease (CVD) outcomes by cholesterol-lowering statin therapy, the high rate of CVD is still a great concern worldwide. Dehydrocorydaline (DHC) is an alkaloidal compound isolated from the traditional Chinese herb Corydalis yanhusuo. Emerging evidence shows that...
Autores principales: | Wen, Bin, Dang, Yuan-ye, Wu, Su-hua, Huang, Yi-min, Ma, Kong-yang, Xu, Yi-ming, Zheng, Xi-Long, Dai, Xiao-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160055/ https://www.ncbi.nlm.nih.gov/pubmed/34552216 http://dx.doi.org/10.1038/s41401-021-00769-3 |
Ejemplares similares
-
Dehydrocorydaline Accounts the Majority of Anti-Inflammatory Property of Corydalis Rhizoma in Cultured Macrophage
por: Kong, Xiangpeng, et al.
Publicado: (2020) -
CD59 Underlines the Antiatherosclerotic Effects of C-Phycocyanin on Mice
por: Li, Bing, et al.
Publicado: (2013) -
LC-MS/MS Determination and Pharmacokinetic Study of Dehydrocorydaline in Rat Plasma after Oral Administration of Dehydrocorydaline and Corydalis yanhusuo Extract
por: Li, Qiu-Yue, et al.
Publicado: (2014) -
Inhibition of Glutamate Release from Rat Cortical Nerve Terminals by Dehydrocorydaline, an Alkaloid from Corydalis yanhusuo
por: Lin, Tzu-Yu, et al.
Publicado: (2022) -
Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA-MB-231 cells
por: Huang, Ying, et al.
Publicado: (2020)